Mercer Global Advisors Inc Immunity Bio, Inc. Transaction History
Mercer Global Advisors Inc
- $58.7 Billion
- Q3 2025
A detailed history of Mercer Global Advisors Inc transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 16,959 shares of IBRX stock, worth $35,274. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,959
Previous 36,824
53.95%
Holding current value
$35,274
Previous $97,000
57.73%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding IBRX
# of Institutions
302Shares Held
137MCall Options Held
2.59MPut Options Held
3.35M-
Vanguard Group Inc Valley Forge, PA27.7MShares$57.5 Million0.0% of portfolio
-
Jane Street Group, LLC New York, NY12.8MShares$26.7 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$23.8 Million0.0% of portfolio
-
State Street Corp Boston, MA11.3MShares$23.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.89MShares$14.3 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $833M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...